De Novo Missense Substitutions in the Gene Encoding CDK8, a Regulator of the Mediator Complex, Cause a Syndromic Developmental Disorder

Eduardo Calpena(University of Oxford), Alexia Hervieu(Institute of Cancer Research), Teresa Kaserer(Institute of Cancer Research), Sigrid M. A. Swagemakers(Erasmus MC), Jacqueline A.C. Goos(Erasmus MC), Olajumoke Adeniji-Popoola(Institute of Cancer Research), María Jesús Ortiz-Ruiz(Institute of Cancer Research), Tina Barbaro‐Dieber(Cook Children's Medical Center), Lucy Bownass(University Hospitals Bristol NHS Foundation Trust), Eva H. Brilstra(Utrecht University), Elise Brimble(Stanford University), Nicola Foulds(University Hospital Southampton NHS Foundation Trust), Theresa A. Grebe(University of Arizona), Aster V. E. Harder(Utrecht University), Melissa Lees(Great Ormond Street Hospital for Children NHS Foundation Trust), Kristin G. Monaghan, Ruth Newbury‐Ecob(University Hospitals Bristol NHS Foundation Trust), Kai‐Ren Ong(Birmingham Women’s and Children’s NHS Foundation Trust), Deborah Osio(Birmingham Women’s and Children’s NHS Foundation Trust), Francis Jeshira Reynoso Santos(Joe DiMaggio Children's Hospital), Maura Ruzhnikov(Stanford University), Aida Telegrafi, Ellen van Binsbergen(Utrecht University), Marieke F. van Dooren(Erasmus MC), Peter J. van der Spek(Erasmus MC), Julian Blagg(Institute of Cancer Research), Stephen R.F. Twigg(University of Oxford), Irene M.J. Mathijssen(Erasmus MC), Paul A. Clarke(Institute of Cancer Research), Andrew O.M. Wilkie(University of Oxford)
The American Journal of Human Genetics
March 21, 2019
Cited by 62Open Access
Full Text

Abstract

The Mediator is an evolutionarily conserved, multi-subunit complex that regulates multiple steps of transcription. Mediator activity is regulated by the reversible association of a four-subunit module comprising CDK8 or CDK19 kinases, together with cyclin C, MED12 or MED12L, and MED13 or MED13L. Mutations in MED12, MED13, and MED13L were previously identified in syndromic developmental disorders with overlapping phenotypes. Here, we report CDK8 mutations (located at 13q12.13) that cause a phenotypically related disorder. Using whole-exome or whole-genome sequencing, and by international collaboration, we identified eight different heterozygous missense CDK8 substitutions, including 10 shown to have arisen de novo, in 12 unrelated subjects; a recurrent mutation, c.185C>T (p.Ser62Leu), was present in five individuals. All predicted substitutions localize to the ATP-binding pocket of the kinase domain. Affected individuals have overlapping phenotypes characterized by hypotonia, mild to moderate intellectual disability, behavioral disorders, and variable facial dysmorphism. Congenital heart disease occurred in six subjects; additional features present in multiple individuals included agenesis of the corpus callosum, ano-rectal malformations, seizures, and hearing or visual impairments. To evaluate the functional impact of the mutations, we measured phosphorylation at STAT1-Ser727, a known CDK8 substrate, in a CDK8 and CDK19 CRISPR double-knockout cell line transfected with wild-type (WT) or mutant CDK8 constructs. These experiments demonstrated a reduction in STAT1 phosphorylation by all mutants, in most cases to a similar extent as in a kinase-dead control. We conclude that missense mutations in CDK8 cause a developmental disorder that has phenotypic similarity to syndromes associated with mutations in other subunits of the Mediator kinase module, indicating probable overlap in pathogenic mechanisms.


Related Papers

No related papers found

Powered by citation graph analysis